A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer.

被引：0
|
作者：
Seiwert, TY
Connell, PP
Mauer, AM
Hoffman, PC
George, CM
Szeto, L
Obasaju, C
Haraf, DJ
Salgia, R
Vokes, EE
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：635S / 635S
页数：1
相关论文
共 50 条
  • [1] Pemetrexed-based concurrent chemoradiotherapy (CRT) for locally advanced or metastatic non-small cell lung or esophageal cancer: A phase I dose-escalating study
    Seiwert, T
    Connell, P
    Mauer, A
    Hoffman, P
    George, C
    Szeto, L
    Salgia, R
    Kayitalire, L
    Haraf, D
    Vokes, E
    LUNG CANCER, 2005, 49 : S80 - S80
  • [2] Phase I dose-escalating study of raltitrexed ('Tomudex') and cisplatin in metastatic non-small cell lung cancer
    Manegold, C
    Buchholz, E
    Kloeppel, R
    Kreisel, C
    Smith, M
    LUNG CANCER, 2002, 36 (02) : 183 - 189
  • [3] Pemetrexed-based chemotherapy in advanced nonsquamous non-small cell lung cancer (NSCLC).
    Alshehri, Abdulrahman Ali
    Alsubait, Saud Abdullrhman
    Alamgir, M. Ahsan
    Park, Chandler
    Wen, Sijin
    Luo, Jin
    Ma, Patrick
    Monga, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Combination of chemotherapy and radiotherapy for locally advanced non-small cell lung cancer
    Fournel, P.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S94 - S100
  • [5] Phase I Study of Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients with Locally Advanced Non-small Cell Lung Cancer
    Li, B.
    Yi, Y.
    Wang, Z.
    Sun, H.
    Gong, H.
    Zhang, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S464 - S465
  • [6] Phase I Study of Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer
    Li, Bao-Sheng
    Gong, He-Yi
    Huang, Wei
    Yi, Yan
    Yu, Jin-Mimg
    Wang, Zhong-Tang
    Zhang, Zi-Cheng
    Sun, Hong-Fu
    Li, Hong-Sheng
    Wang, Li-Ying
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (02): : 115 - 119
  • [7] Preface - Lung cancer, part I: radiotherapy and chemotherapy in locally advanced and metastatic non-small cell lung cancer
    Jeremic, B
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (01) : XVII - XVIII
  • [8] A phase I study of pernetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer
    Seiwert, Tanguy Y.
    Connel, Philip P.
    Mauer, Ann M.
    Hoffman, Philip C.
    George, Christopher M.
    Szeto, Livia
    Salgia, Ravi
    Posther, Katherine E.
    Nguyen, Binh
    Haraf, Daniel J.
    Vokes, Everett E.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 515 - 522
  • [9] Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK plus Non-Small Cell Lung Cancer
    Jo, Jaemin
    Kim, Se Hyun
    Kim, Yu Jung
    Lee, Juhyun
    Kim, Miso
    Keam, Bhumsuk
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    Chung, Jin-Haeng
    Jeon, Yoon Kyung
    Lee, Jong Seok
    YONSEI MEDICAL JOURNAL, 2018, 59 (02) : 202 - 210
  • [10] Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer
    Shaw, A. T.
    Varghese, A. M.
    Solomon, B. J.
    Costa, D. B.
    Novello, S.
    Mino-Kenudson, M.
    Awad, M. M.
    Engelman, J. A.
    Riely, G. J.
    Monica, V.
    Yeap, B. Y.
    Scagliotti, G. V.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 59 - 66
12345